Artículos de revistas sobre el tema "Theraputic use"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Theraputic use".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Castro, M. Regina. "Thyroid Nodules—Management Dilemmas and Theraputic Considerations". US Endocrinology 00, n.º 01 (2005): 1. http://dx.doi.org/10.17925/use.2005.00.01.1f.
Texto completoCastro, M. Regina. "Thyroid Nodules - Management Dilemmas and Theraputic Considerations". US Endocrinology 00, n.º 01 (2005): 68. http://dx.doi.org/10.17925/use.2005.00.01.68.
Texto completoGuancial, Elizabeth A., Vinay S. Mahajan, Ronald P. McCaffrey y Neal Lindeman. "Theraputic Monoclonal Antibody Interference In Immunofixation Electrophoresis". Blood 116, n.º 21 (19 de noviembre de 2010): 4996. http://dx.doi.org/10.1182/blood.v116.21.4996.4996.
Texto completoNeff, Lucas P., Justin M. Allman y James H. Holmes. "The use of theraputic plasma exchange (TPE) in the setting of refractory burn shock". Burns 36, n.º 3 (mayo de 2010): 372–78. http://dx.doi.org/10.1016/j.burns.2009.05.006.
Texto completoPoudel, Parashu Ram. "Physics in Medical Science". Himalayan Physics 2 (31 de julio de 2011): 43–46. http://dx.doi.org/10.3126/hj.v2i2.5210.
Texto completoMueller, Joseph, Ryan Yao, Kim Selting, Catherine Best-Popescu, Brendan Harley y Sara Pedron-Haba. "Abstract A045: Engineered systems for tumor modeling facilitate the assessment of theraputic interventions". Cancer Research 84, n.º 5_Supplement_1 (4 de marzo de 2024): A045. http://dx.doi.org/10.1158/1538-7445.brain23-a045.
Texto completoAknouk, Mina y Kenny Chiu. "S2608 Hemospray, a Novel Theraputic Use to Control Rectal Bleeding in a Case of Refractory Hemorrhagic Radiation Proctitis". American Journal of Gastroenterology 117, n.º 10S (octubre de 2022): e1727-e1728. http://dx.doi.org/10.14309/01.ajg.0000867072.17772.0c.
Texto completoMatsumoto, K., H. Kikuchi, S. Kano, H. Iri, H. Takahashi y M. Umino. "Automated determination of drugs in serum by liquid chromatography with column-switching. I. Separation of antiepileptic drugs and metabolites." Clinical Chemistry 34, n.º 1 (1 de enero de 1988): 141–44. http://dx.doi.org/10.1093/clinchem/34.1.141.
Texto completoJoshi, SN, M. Chaudhary, D. Bhattarai, S. Gnyawali, G. S. Shrestha y P. Adhikari. "Theraputic application if Poly-2-hydroxy ethyl mathacrylate contact lens in various ocular surface disorders among Nepalese population". Journal of Institute of Medicine Nepal 37, n.º 2 (30 de agosto de 2015): 35–39. http://dx.doi.org/10.59779/jiomnepal.713.
Texto completoMentrup, Heather, Anna Ramos, Elizabeth Novak, Steven Ballesteros, Erin Crawford, Meredith Flanagan y Kevin Mollen. "MITOCHONDRIAL TURNOVER IS ELEVATED IN RESPONSE TO INTESTINAL INFLAMMATION AND IS AMENABLE TO THERAPUTIC TARGETING VIA UROLITHIN A". Inflammatory Bowel Diseases 30, Supplement_1 (25 de enero de 2024): S3—S4. http://dx.doi.org/10.1093/ibd/izae020.008.
Texto completoJnaidi, Raneem, António José Almeida y Lídia M. Gonçalves. "Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme". Pharmaceutics 12, n.º 9 (10 de septiembre de 2020): 860. http://dx.doi.org/10.3390/pharmaceutics12090860.
Texto completoHuque, Muhammed Moinul, Ashraf Ul Huq, Kaniz Hasina y Md Jafrul Hannan. "Role of laparoscopy in the management of impalpable testis in children: Approach in our country". Journal of Paediatric Surgeons of Bangladesh 8, n.º 1 (9 de diciembre de 2018): 15–19. http://dx.doi.org/10.3329/jpsb.v8i1.69632.
Texto completoMishra, Alka y Vandana Shrivastava. "Exploring the Science of Marma - An Ancient Healing Technique: Marma Therapy". Dev Sanskriti Interdisciplinary International Journal 22 (4 de agosto de 2023): 23–37. http://dx.doi.org/10.36018/dsiij.v20i.157.
Texto completoAlperovich, Michael, Keith M. Blechman, Fares Samra, Richard Shapiro, Deborah M. Axelrod, Mihye Choi, Nolan S. Karp y Amber Azniv Guth. "Nipple-sparing mastectomy and subareolar biopsy: To freeze or not to freeze?" Journal of Clinical Oncology 30, n.º 27_suppl (20 de septiembre de 2012): 185. http://dx.doi.org/10.1200/jco.2012.30.27_suppl.185.
Texto completoGowda, Chandrika S., Chunhua Song, Sunil Muthusami, Yali Ding, Mansi Sachdev, Kimberly Payne y Sinisa Dovat. "Restoring Ikaros Function in Leukemia : Casein Kinase II ( CK2) Inhibition Restores Ikaros Tumor Supressor Function and Shows Theraputic Efficacy in Preclinical Models of High Risk Pediatric Leukemia". Blood 124, n.º 21 (6 de diciembre de 2014): 3712. http://dx.doi.org/10.1182/blood.v124.21.3712.3712.
Texto completoKhillan, Ratesh, Kamudi Somnay y Raj Wadgaonkar. "Therapuetic Use of Alum in Radiation Proctitis". American Journal of Gastroenterology 100 (septiembre de 2005): S283. http://dx.doi.org/10.14309/00000434-200509001-00758.
Texto completoLu, Sydney X., Lucy Willis, Marsinay Smith, David Suh, Christopher King, Johanne Bautista, Melanie Chow et al. "CEACAM-1 Is Involved in Graft-Versus-Host-Disease in Murine Allogeneic Bone Marrow Transplantation Models." Blood 110, n.º 11 (16 de noviembre de 2007): 67. http://dx.doi.org/10.1182/blood.v110.11.67.67.
Texto completoThasneem, K. V. Musaina, K. Sreejith, B. Athulnadh, Namitha Maniyan, Cherakkulath C. Neena y P. P. Muhamed Faris. "SGLT2 Inhibitors: A Noval Therapuetic Agent in the Treatment of Diabetic Kidney Disease". Journal of Drug Delivery and Therapeutics 10, n.º 6 (15 de noviembre de 2020): 203–6. http://dx.doi.org/10.22270/jddt.v10i6.4532.
Texto completoDanon, Limor Meoded, Vanessa Bähr, Elad Schiff, Miriam Ortiz, Benno Brinkhaus y Barbara Stöckigt. "Learning to Establish a Therapeutic Doctor-Patient Communication: German and Israeli Medical Students Experiencing Integrative Medicine’s Skills". Social Science, Humanities and Sustainability Research 2, n.º 4 (27 de octubre de 2021): p48. http://dx.doi.org/10.22158/sshsr.v2n4p48.
Texto completoAntonelli, Massimo, Giorgio Conti, Andrea Belisari, Lucia S. D'Angiolella, Lorenzo Mantovani, Sabato Montella, Patrizio Piacentini y Marco Ranieri. "The use of dexmedetomidine in intensive care sedation". Farmeconomia. Health economics and therapeutic pathways 14, n.º 1S (28 de mayo de 2013): 1–28. http://dx.doi.org/10.7175/fe.v14i1s.674.
Texto completoKalra, Kavita B., Xiangfei Cheng, Marion Womak, Christopher Gocke, Jyoti B. Patel, Vincent C. O. Njar y Naoko Takebe. "Novel Retinoic Acid Metabolism Blocking Agents (RAMBAs) Induce Differentiation in ATRA Resistant Cell Line: Potential New Theraputics for Acute Promyleocytic Leukemia (APL)." Blood 106, n.º 11 (16 de noviembre de 2005): 746. http://dx.doi.org/10.1182/blood.v106.11.746.746.
Texto completoInklebarger J, James Inklebarger J., Mr Giles Gyer, Nikiforos Galanis, Mr Jimmy Michael y Dr Ghulam Adel. "Cinchona Bark For The Treatment Of Covid-19 Pnemonia: A Modern Review Of The Potential Anti-Viral Therapuetic Applications Of An Old Treatment". International Journal of Medical Science and Clinical invention 7, n.º 05 (1 de mayo de 2020): 4795–801. http://dx.doi.org/10.18535/ijmsci/v7i05.02.
Texto completoRiedell, Peter A., Jamie Brower, Loretta Nastoupil, Miguel-Angel Perales, Richard T. Maziarz, Joseph P. McGuirk, Veronika Bachanova et al. "A Multicenter Analysis of Outcomes, Toxicities, and Patterns of Use with Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B-Cell Lymphomas". Blood 138, Supplement 1 (5 de noviembre de 2021): 2512. http://dx.doi.org/10.1182/blood-2021-151971.
Texto completoLalu, Manoj M., Dean A. Fergusson, Wei Cheng, Marc T. Avey, Dale Corbett, Dar Dowlatshahi, Malcolm R. Macleod et al. "Identifying stroke therapeutics from preclinical models: A protocol for a novel application of network meta-analysis". F1000Research 8 (3 de enero de 2019): 11. http://dx.doi.org/10.12688/f1000research.15869.1.
Texto completoSvoboda, Jakub, Hatcher J. Ballard, Carrie I. Ho, Mitchell E. Hughes, Elise A. Chong, Adam Duca, Sara Prischak et al. "Safety and Efficacy of Sars-Cov-2 Vaccines in Hodgkin Lymphoma Patients Receiving PD-1 Inhibitors". Blood 138, Supplement 1 (5 de noviembre de 2021): 2445. http://dx.doi.org/10.1182/blood-2021-153122.
Texto completoJones, J. A., J. Flynn, M. Moran, T. Lin y J. Byrd. "Trends in pneumonia (PNA) hospitalization among patients (pts) with chronic lymphocytic leukemia (CLL)". Journal of Clinical Oncology 27, n.º 15_suppl (20 de mayo de 2009): e20500-e20500. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e20500.
Texto completoGordeuk, Victor R., Barbara Kroner, Norma Pugh, Jane S. Hankins, Abdullah Kutlar, Allison A. King, Nirmish Shah, Julie Kanter, Jeffrey Glassberg y Marsha Treadwell. "Hydroxyurea Use and Outcomes of Pregnancy in Sickle Cell Disease". Blood 136, Supplement 1 (5 de noviembre de 2020): 33. http://dx.doi.org/10.1182/blood-2020-143315.
Texto completoChristopoulos, Georgios, Zachi I. Attia, Peter A. Noseworthy, Timothy G. Call, Wei Ding, Jose F. Leis, Eli Muchtar et al. "Use of Artificial Intelligence Electrocardiography to Predict Atrial Fibrillation (AF) in Patients with Chronic Lymphocytic Leukemia (CLL)". Blood 136, Supplement 1 (5 de noviembre de 2020): 50–51. http://dx.doi.org/10.1182/blood-2020-142645.
Texto completoCarniti, Cristiana, Chiara Monfrini, Vanessa Aragona, Martina Magni, Cristina Vella, Eugenio Fardella, Riccardo Betta et al. "Tisagenlecleucel and Axicabtagene Ciloleucel Expansion Kinetics and CAR T Cell Attributes in the Infusion Products Are Early Predictors of Clinical Efficacy". Blood 138, Supplement 1 (5 de noviembre de 2021): 3877. http://dx.doi.org/10.1182/blood-2021-152309.
Texto completoThompson, Meghan C., Lindsey E. Roeker, Catherine C. Coombs, Jeffrey L. Jensen, Manali Kamdar, Alan Skarbnik, John M. Pagel et al. "Addressing a New Challenge in Chronic Lymphocytic Leukemia: Outcomes of Therapies after Exposure to Both a Covalent Bruton's Tyrosine Kinase Inhibitor and Venetoclax". Blood 138, Supplement 1 (5 de noviembre de 2021): 2628. http://dx.doi.org/10.1182/blood-2021-150751.
Texto completoGlaspy, John, Tom Tang, Dean Rutty, Xiaoqiang Yan, Igor Bondarenko y Dmitrii Krasnozhon. "A Phase II, Randomized, Multi-Centre, Open-Label, Active-Controlled, Dose-Finding Trial of F-627 (benefilgrastim) in Women with Breast Cancer Receiving Myelotoxic Chemotherapy". Blood 124, n.º 21 (6 de diciembre de 2014): 1584. http://dx.doi.org/10.1182/blood.v124.21.1584.1584.
Texto completoKuruvilla, Philip, Juhi Husain, Henry J. Conter, William To-Dang, Margaret Balcewicz y Stephen Reingold. "Real World Experience of Ibrutinib in an Ethnically Diverse Canadian Community Hospital". Blood 142, Supplement 1 (28 de noviembre de 2023): 6549. http://dx.doi.org/10.1182/blood-2023-172977.
Texto completoDiamond, Akiva, Sabarish Ayyappan, Shufen Cao, Nour Tashtish, Kirsten M. Boughan, Brenda W. Cooper, Pingfu Fu y Paolo F. Caimi. "Development of a Risk Score for Cardiovascular Events in Anthracycline Treated DLBCL Patients". Blood 138, Supplement 1 (5 de noviembre de 2021): 2536. http://dx.doi.org/10.1182/blood-2021-153862.
Texto completoAmonoo, Hermioni L., Areej El-Jawahri, Thomas W. LeBlanc, Alison R. Kavanaugh, Jason A. Webb, Lara Traeger, Annemarie D. Jagielo et al. "Post-Traumatic Stress Disorder (PTSD) Symptoms in Patients with Acute Myeloid Leukemia (AML)". Blood 136, Supplement 1 (5 de noviembre de 2020): 44–45. http://dx.doi.org/10.1182/blood-2020-133857.
Texto completoSaultz, Jennifer N., Kaycee Moshofsky, Andy Kaempf, Guang Fan, Gabrielle Meyers, Rachel J. Cook, Richard T. Maziarz, Peggy Appel, Francisco Tria y Staci Williamson. "Early Infection after Allogeneic Transplant Increases NRM without Influencing Relapse Rate". Blood 136, Supplement 1 (5 de noviembre de 2020): 21. http://dx.doi.org/10.1182/blood-2020-142048.
Texto completoMasese, Rita V., Dominique Bulgin, Mitchell Knisely, Liliana Preiss, Eleanor Stevenson, Jane S. Hankins, Marsha Treadwell et al. "Sex Based Differences in Sickle Cell Disease". Blood 136, Supplement 1 (5 de noviembre de 2020): 37. http://dx.doi.org/10.1182/blood-2020-140896.
Texto completoHeitzer, Andrew M., Jennifer Longoria, Evadnie Rampersaud, Sara Rashkin, Jeremie H. Estepp, Victoria Okhomina, Winfred Wang et al. "Fetal Hemoglobin Mediates the Effect of Beta Globin Gene Polymorphisms on Neurocognitive Functioning in Sickle Cell Disease". Blood 136, Supplement 1 (5 de noviembre de 2020): 23–24. http://dx.doi.org/10.1182/blood-2020-137065.
Texto completoMasese, Rita V., Dominique Bulgin, Liliana Preiss, Mitchell Knisely, Eleanor Stevenson, Jane S. Hankins, Marsha Treadwell et al. "Predictors of Maternal Morbidity Among Participants Enrolled in the Sickle Cell Disease Implementation Consortium Registry". Blood 136, Supplement 1 (5 de noviembre de 2020): 3. http://dx.doi.org/10.1182/blood-2020-140743.
Texto completoWang, Zhiquan, Justin C. Boysen, Huihuang Yan, Charla R. Secreto, Sameer A. Parikh, Saad S. Kenderian, Wei Ding, Esteban Braggio, Susan L. Slager y Neil E. Kay. "Targeting Aberrant Chromatin in Chronic Lymphocytic Leukemia". Blood 136, Supplement 1 (5 de noviembre de 2020): 1. http://dx.doi.org/10.1182/blood-2020-140309.
Texto completoHampel, Paul J., Sameer A. Parikh, Timothy G. Call, Mithun Vinod Shah, Nabila Bennani, Aref Al-Kali, Kari G. Rabe et al. "Venetoclax Has Modest Efficacy in the Treatment of Patients with Relapsed T-Cell Prolymphocytic Leukemia". Blood 136, Supplement 1 (5 de noviembre de 2020): 39–40. http://dx.doi.org/10.1182/blood-2020-134586.
Texto completoCosta, Luciano J., Sandy W. Wong, Arancha Bermúdez, Javier de la Rubia, María-Victoria Mateos, Enrique M. Ocio, Paula Rodríguez-Otero et al. "First Clinical Study of the B-Cell Maturation Antigen (BCMA) 2+1 T Cell Engager (TCE) CC-93269 in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Interim Results of a Phase 1 Multicenter Trial". Blood 134, Supplement_1 (13 de noviembre de 2019): 143. http://dx.doi.org/10.1182/blood-2019-122895.
Texto completoAbrisqueta, Pau, Juan-Manuel Sancho, Raul Cordoba, Daniel O. Persky, Charalambos Andreadis, Scott F. Huntington, Cecilia Carpio et al. "Anti-CD47 Antibody, CC-90002, in Combination with Rituximab in Subjects with Relapsed and/or Refractory Non-Hodgkin Lymphoma (R/R NHL)". Blood 134, Supplement_1 (13 de noviembre de 2019): 4089. http://dx.doi.org/10.1182/blood-2019-125310.
Texto completoFoster, Matthew C., Philip A. Roehrs, George E. Hucks, Natalie S. Grover, Paul M. Armistead, Katarzyna Jamieson, Faith Brianne Buchanan et al. "Safety and Antitumor Effects of CD19-Specific Autologous Chimeric Antigen Receptor-Modified T (CAR-T) Cells Expressing the Inducible Caspase 9 Safety Switch (iC9-CAR19 T Cells) in Adult Acute Lymphoblastic Leukemia (ALL)". Blood 136, Supplement 1 (5 de noviembre de 2020): 36–37. http://dx.doi.org/10.1182/blood-2020-139051.
Texto completoKamdar, Manali, Scott R. Solomon, Jon E. Arnason, Patrick B. Johnston, Bertram Glass, Veronika Bachanova, Sami Ibrahimi et al. "Lisocabtagene Maraleucel (liso-cel), a CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy, Versus Standard of Care (SOC) with Salvage Chemotherapy (CT) Followed By Autologous Stem Cell Transplantation (ASCT) As Second-Line (2L) Treatment in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Randomized Phase 3 Transform Study". Blood 138, Supplement 1 (5 de noviembre de 2021): 91. http://dx.doi.org/10.1182/blood-2021-147913.
Texto completoZeidan, Amer M., Daniel J. DeAngelo, Jeanne M. Palmer, Christopher S. Seet, Martin S. Tallman, Xin Wei, Ying Fei Li et al. "A Phase I Study of CC-90002, a Monoclonal Antibody Targeting CD47, in Patients with Relapsed and/or Refractory (R/R) Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS): Final Results". Blood 134, Supplement_1 (13 de noviembre de 2019): 1320. http://dx.doi.org/10.1182/blood-2019-125363.
Texto completoBishop, Michael R., Michael Dickinson, Duncan Purtill, Pere Barba, Armando Santoro, Nada Hamad, Koji Kato et al. "Tisagenlecleucel Vs Standard of Care As Second-Line Therapy of Primary Refractory or Relapsed Aggressive B-Cell Non-Hodgkin Lymphoma: Analysis of the Phase III Belinda Study". Blood 138, Supplement 2 (4 de diciembre de 2021): LBA—6—LBA—6. http://dx.doi.org/10.1182/blood-2021-155068.
Texto completoConnor, John, Fredrick Rappaport y Ihor S. Sawczuk. "Results with the Use of MVAC in Theraputic and Adjunctive Settings". Journal of Urology 137, n.º 6 (junio de 1987). http://dx.doi.org/10.1016/s0022-5347(17)75812-0.
Texto completoThakur, Santosh Kumar, Sumit Natthani y Mita Kotecha. "PRIMITIVE THERAPUTIC BIDS OF MEDICINAL PLANT ROHITAKATECOMELLA UNDULATA (SM.) SEEM.: A COMPREHENSIVE APPRAISAL BASED ON CLASSICAL AYURVEDA TEXTS". GLOBAL JOURNAL FOR RESEARCH ANALYSIS, 15 de agosto de 2020, 17–20. http://dx.doi.org/10.36106/gjra/5603204.
Texto completoLi, Yimin, Yonglin Yi, Anqi Lin, Peng Luo y Jian Zhang. "A comparison of the efficacy of antiangiogenic agents combined with chemotherapy for the treatment of non-small cell lung cancer: a network meta-analysis". Cancer Cell International 20, n.º 1 (10 de noviembre de 2020). http://dx.doi.org/10.1186/s12935-020-01639-4.
Texto completoOnallah, Hadil, Ronen Hazan y Ran Nir-Paz. "2142. The use of Pseudomonas aeruginosa Phage PASA16 for non resolving infections". Open Forum Infectious Diseases 10, Supplement_2 (27 de noviembre de 2023). http://dx.doi.org/10.1093/ofid/ofad500.1765.
Texto completo